chlordiazepoxide has been researched along with antipyrine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Abernethy, DR; Divoll, MK; Greenblatt, DJ; Harmatz, JS; Ochs, HR; Shader, RI | 1 |
| Cowger, ML; Labbe, RF | 1 |
| Breckenridge, A; Moss, DW; Neale, G; Orme, M; Whitfield, JB | 1 |
| Hofstetter, JR; Realini, S | 1 |
| Breckenridge, A; Orme, M | 1 |
| Hiley, CR; Wilson, AC | 1 |
| COSIN, M; FERRERAS, E | 1 |
1 trial(s) available for chlordiazepoxide and antipyrine
| Article | Year |
|---|---|
[Therapy of the irritable colon using a new drug combination (chlordiazepoxide, clidinium bromide, propyphenazone)].
Topics: Antipyrine; Chlordiazepoxide; Colonic Diseases; Drug Combinations; Humans; Parasympatholytics; Propane; Quaternary Ammonium Compounds; Quinuclidines; Spasm | 1973 |
12 other study(ies) available for chlordiazepoxide and antipyrine
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition.
Topics: Adult; Aging; Antipyrine; Body Weight; Chlordiazepoxide; Female; Half-Life; Humans; Injections, Intravenous; Male; Sex Factors | 1989 |
The inhibition of terminal oxidation by porphyrinogenic drugs.
Topics: Animals; Antipyrine; Barbiturates; Carbamates; Cattle; Chlordiazepoxide; Chlorobutanol; Culture Techniques; Electron Transport; Glycolysis; Griseofulvin; Hexachlorocyclohexane; Lactates; Mice; Mitochondria; Oxidoreductases; Pharmacology; Porphyrias; Porphyrins; Pyridines; Steroids | 1967 |
Changes in plasma -glutamyl transpeptidase activity associated with alterations in drug metabolism in man.
Topics: Acyltransferases; Adult; Aged; Amobarbital; Antipyrine; Chlordiazepoxide; Diazepam; Enzyme Induction; Female; gamma-Glutamyltransferase; Humans; Male; Methaqualone; Middle Aged; Nitrazepam; Secobarbital; Time Factors; Warfarin | 1973 |
Clinical implications of enzyme induction.
Topics: Alcohols; Amobarbital; Animals; Antipyrine; Benzazepines; Blood Coagulation; Chloral Hydrate; Chlordiazepoxide; Enzyme Induction; Ethanol; Fluorometry; Half-Life; Humans; Hydrocortisone; Hypnotics and Sedatives; Ketones; Kinetics; Male; Metabolism; Microsomes, Liver; Morphinans; Nitro Compounds; Paralysis; Phenobarbital; Rats; Rheumatic Heart Disease; Secobarbital; Sleep; Time Factors; Warfarin | 1971 |
Effects of some hepatomegalic agents on liver DNA content: relationship to changes in liver blood flow.
Topics: Animals; Antipyrine; Chlordiazepoxide; DNA; Liver; Liver Circulation; Male; Methylprednisolone; Organ Size; Proteins; Rats; Rats, Inbred Strains | 1983 |
[Clinico-experimental study with a new spasmolytic-analgesic preparation, Ro 4-4395].
Topics: Analgesics; Antipyrine; Biliary Dyskinesia; Chlordiazepoxide; Cholelithiasis; Deglutition Disorders; Diarrhea; Dysmenorrhea; Female; Humans; Parasympatholytics; Pyelitis; Urinary Calculi | 1963 |